Acer Therapeutics Inc.
One Gateway Center, Suite 351
300 Washington Street
Newton, MA 02458
April 28, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-0409
Attention: | Michael Davis |
Re: | Acer Therapeutics Inc. |
Registration Statement on Form S-3 |
File No. 333-264378 |
Request for Acceleration of Effectiveness |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Acer Therapeutics Inc. hereby requests that the effective date of the above-captioned registration statement on Form S-3 (the “Registration Statement”) be accelerated to 5:00 p.m., Eastern Time, on Monday, May 2, 2022, or as soon thereafter as may be practicable.
Sincerely, | ||
ACER THERAPEUTICS INC. | ||
By: | /s/ Harry S. Palmin | |
Name: | Harry S. Palmin | |
Title: | Chief Operating Officer and Chief Financial Officer |
cc: | Patty M. DeGaetano, Esq. |